- Featured Product
- KD/KO Validated
Apolipoprotein AI Polyklonaler Antikörper
Apolipoprotein AI Polyklonal Antikörper für WB, IHC, IF/ICC, IF-P, FC (Intra), ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus
Anwendung
WB, IHC, IF/ICC, IF-P, FC (Intra), IP, ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 14427-1-AP
Synonyme
Geprüfte Anwendungen
| Erfolgreiche Detektion in WB | humanes Blutgewebe, humanes Hirngewebe, humanes Ileumgewebe |
| Erfolgreiche Detektion in IHC | humanes Leberkarzinomgewebe, humanes Lebergewebe, humanes Lungengewebe Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen. |
| Erfolgreiche Detektion in IF-P | Mauslebergewebe |
| Erfolgreiche Detektion in IF/ICC | HeLa-Zellen |
| Erfolgreiche Detektion in FC (Intra) | HepG2-Zellen |
Empfohlene Verdünnung
| Anwendung | Verdünnung |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunhistochemie (IHC) | IHC : 1:50-1:500 |
| Immunfluoreszenz (IF)-P | IF-P : 1:50-1:500 |
| Immunfluoreszenz (IF)/ICC | IF/ICC : 1:50-1:500 |
| Durchflusszytometrie (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Veröffentlichte Anwendungen
| KD/KO | See 1 publications below |
| WB | See 33 publications below |
| IHC | See 10 publications below |
| IF | See 4 publications below |
| IP | See 2 publications below |
Produktinformation
14427-1-AP bindet in WB, IHC, IF/ICC, IF-P, FC (Intra), IP, ELISA Apolipoprotein AI und zeigt Reaktivität mit human, Maus
| Getestete Reaktivität | human, Maus |
| In Publikationen genannte Reaktivität | human, Maus |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | Apolipoprotein AI fusion protein Ag5793 |
| Vollständiger Name | apolipoprotein A-I |
| Berechnetes Molekulargewicht | 31 kDa |
| Beobachtetes Molekulargewicht | 26-30 kDa |
| GenBank-Zugangsnummer | BC005380 |
| Gene symbol | APOA1 |
| Gene ID (NCBI) | 335 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS with 0.02% sodium azide and 50% glycerol |
| Lagerungsbedingungen | Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
ApoA1 is a major protein component of high density lipoproteins (HDL) which is associated with reversed cholesterol transport, lipid/cholesterol binding, lecithin/cholesterol acyltransferase (LCAT) activation and specific receptors binding. It is synthesized in the liver and small intestine. Defects of ApoA1 cause low HDL level and systemic non-neuropathic amyloidosis. Serum concentration of ApoA1 is inversely related to the risk of developing atherosclerosis. This antibody was generated against the C-terminal region of human ApoA1.
Protokolle
| PRODUKTSPEZIFISCHE PROTOKOLLE | |
|---|---|
| WB protocol for Apolipoprotein AI antibody 14427-1-AP | Protokoll herunterladen |
| IHC protocol for Apolipoprotein AI antibody 14427-1-AP | Protokoll herunterladenl |
| IF protocol for Apolipoprotein AI antibody 14427-1-AP | Protokoll herunterladen |
| STANDARD-PROTOKOLLE | |
|---|---|
| Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |
Publikationen
| Species | Application | Title |
|---|---|---|
Science Enterically derived high-density lipoprotein restrains liver injury through the portal vein. | ||
Neuron Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory. | ||
J Control Release Lipid-mediated protein corona regulation with increased apolipoprotein A-I recruitment for glioma targeting | ||
Br J Cancer A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline. | ||
Theranostics Exosome-mediated delivery of inflammation-responsive Il-10 mRNA for controlled atherosclerosis treatment | ||
Br J Pharmacol A novel apoA-I mimetic peptide suppresses atherosclerosis by promoting physiological HDL function in apoE-/- mice. |
Rezensionen
The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.
FH Alexandre (Verified Customer) (02-28-2019) | Detection of both human and mouse APOA1 protein by westernblotImmunoprecipitation of both human and mouse APOA1
![]() |













